These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10820894)

  • 21. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of 'Fixed' combination preparations of inhaled short acting b-2 agonists and inhaled corticosteroids.
    Gupta A
    Indian Pediatr; 2000 Jul; 37(7):752-4. PubMed ID: 10906807
    [No Abstract]   [Full Text] [Related]  

  • 23. Asthma therapy with aerosols: clinical relevance for the next decade.
    Barnes PJ
    J Aerosol Med; 1996; 9(1):131-41. PubMed ID: 10160203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caution with inhaled corticosteroids in childhood asthma.
    Welch MJ
    West J Med; 1995 Oct; 163(4):371-2. PubMed ID: 7483599
    [No Abstract]   [Full Text] [Related]  

  • 25. The problem of dose-response and therapeutic ratio of inhaled steroids.
    Edsbäcker S
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1758-9. PubMed ID: 11458876
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
    Harrison TW; Wisniewski A; Honour J; Tattersfield AE
    Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An assessment of steroid hypersensitivity in asthma.
    Wilkinson SM; Higgins B; Owen S; Mattey DL; Woodcock A
    Respir Med; 1997 Apr; 91(4):231-3. PubMed ID: 9156146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The problem of dose-response and therapeutic ratio of inhaled steroids.
    Lipworth BJ
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1758; author reply 1759. PubMed ID: 11401902
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newer therapeutic agents for asthma.
    Deykin A; Israel E
    Adv Intern Med; 1999; 44():209-37. PubMed ID: 9929710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cutaneous complications of inhaled corticoids].
    Guillot B; Godard P
    Ann Dermatol Venereol; 1998 Dec; 125(12):927-30. PubMed ID: 9922874
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
    Green RH; Brightling CE; McKenna S; Hargadon B; Neale N; Parker D; Ruse C; Hall IP; Pavord ID
    Eur Respir J; 2006 Jun; 27(6):1144-51. PubMed ID: 16455831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial.
    Rowe BH; Bota GW; Fabris L; Therrien SA; Milner RA; Jacono J
    JAMA; 1999 Jun; 281(22):2119-26. PubMed ID: 10367823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory bronchial polyps associated with asthma: resolution with inhaled corticosteroid.
    Niimi A; Amitani R; Ikeda T; Kubo Y; Tanaka E; Kuze F
    Eur Respir J; 1995 Jul; 8(7):1237-9. PubMed ID: 7589412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Holding chambers versus nebulisers for inhaled steroids in chronic asthma.
    Cates CJ; Adams N; Bestall J
    Cochrane Database Syst Rev; 2001; (2):CD001491. PubMed ID: 11405994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment.
    Gershman NH; Wong HH; Liu JT; Fahy JV
    Eur Respir J; 2000 Jan; 15(1):11-8. PubMed ID: 10678614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
    Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
    Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma.
    Skoner DP; Szefler SJ; Welch M; Walton-Bowen K; Cruz-Rivera M; Smith JA
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):259-68. PubMed ID: 10669845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is fluticasone propionate superior to the other available inhaled steroids?
    Spahn JD
    J Asthma; 1998; 35(4):307-11. PubMed ID: 9669825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.